Overcome the Immunogenicity Limitations To Reach The Largest Population

Time: 2:00 pm
day: Track A - Day 1 PM


  • Current limitations of gene transfer with AAV vectors
  • Next generation vectors to overcome pre-existing humoral immunity to increase the reach of AAV gene therapy
  • Next generation vectors and new methods to overcome post-treatment humoral immunity toward repeated vector administration